HCID 86733148、化合物 → HCID 86733140、化合物

HRID 267643ノート

反応式

HRID 267643 の反応式
[C:1]([C@H:4]1[CH2:9][CH2:8][C@H:7]2[C@H:10]3[C@H:20]([CH2:21][CH2:22][C@:5]12[CH3:6])[C@:18]1([CH3:19])[C@H:13]([CH2:14][C:15](=[O:23])[CH2:16][CH2:17]1)[CH2:12][CH2:11]3)(=O)[NH2:2]>C(Cl)(Cl)Cl>[C:1]([C@H:4]1[CH2:9][CH2:8][C@H:7]2[C@H:10]3[C@H:20]([CH2:21][CH2:22][C@:5]12[CH3:6])[C@:18]1([CH3:19])[C@H:13]([CH2:14][C:15](=[O:23])[CH2:16][CH2:17]1)[CH2:12][CH2:11]3)#[N:2]

参加物

3

実験手順

A solution of 17β-carbamoyl-5α-androstan-3-one (2.4 g.) and polyphosphate ester (12 g.) in chloroform (125 ml.) was refluxed for 24 hours. After removing the chloroform by evaporation aqueous 10% sodium carbonate (100 ml.) was added, the mixture cooled, and extracted with ether. The ethereal extracts were washed with water, dried (MgSO4), filtered and evaporated to afford a buff solid (2.45 g.). Purification by preparative t.l.c. (ethanol/chloroform 1:19) afforded a solid (1.48 g.) which was further purified by passing through a florisil column and crystallisation from dichloromethane/petrol to give title compound (915 mg.) m.p. 150°-152°; [α]D + 89° (c 1.12%).

後処理

  1. customAfter removing the chloroform
  2. customby evaporation aqueous 10% sodium carbonate (100 ml.)
  3. additionwas added
  4. temperaturethe mixture cooled
  5. extractionextracted with ether
  6. washThe ethereal extracts were washed with water
  7. dry with materialdried (MgSO4)
  8. filtrationfiltered
  9. customevaporated
  10. customto afford a buff solid (2.45 g.)
  11. customPurification by preparative t.l.c
  12. custom(ethanol/chloroform 1:19) afforded a solid (1.48 g.) which
  13. customwas further purified
  14. customby passing through a florisil column and crystallisation from dichloromethane/petrol

出典と根拠

ORDレコード
ord-4a1c37e91577429c8371b1c93d00dff8
出典データセット
uspto-grants-1976_03
特許番号
US03943124

反応ノート

読み込み中…